
REVIEW ARTICLE
Evidence Based Medicine Series
NM Lai, MRCP, MRCPCH Department of Paediatrics, School of Medicine and Health Sciences, Monash University Malaysia.
Address for correspondence: Dr Lai Nai Ming, Senior Lecturer in Paediatrics, School of Medicine and Health Sciences, Monash University Malaysia, JKR 1235, Bukit Azah, 80100 Johor Bahru, Johor, Malaysia. Tel: +607 2190600, Fax : +607 2190601, Email: lainm123@yahoo.co.uk
Lai NM. Evidence Based Medicine Series. Part 2. Asking focused answerable clinical questions. Malaysian Family Physician. 2009; 4(1):23-25.
Identifying the need for new information from important and relevant issues in patient care in the face of clinical uncertainties, and converting this need into answerable questions is the first step of Evidence Based Medicine (EBM).1 Different types of questions come up in our minds during the bedside rounds or clinic consults. Some are questions that concern general knowledge, the answers of which are readily available in the standard texts. For example:
What causes Hand Foot Mouth Disease?
What should we use to treat migraine?
How common is hip pain in the elderly?
When (at what age) should we start screening for breast cancer?
How does liver become enlarged with heart failure?
These are “Background questions”, with two major components: A question root (what, why, when, where, how) linking with a disorder, test, treatment or health care issue2. Most background questions have answers that increase knowledge and the amount of information that we can share with patients, but they generally do not help directly in improving patient care. Other background questions are unanswerable, for example question no 2, because whatever answer to these questions will amount to inappropriate generalization, as the questions do not consider specific patient characteristics and outcomes of interest, which are essential elements to consider in deciding whether certain treatment should be used in different clinical circumstances.
With some “touch-ups”, background questions can be converted to specific questions with direct bearing on clinical decisions - the “foreground questions”. For example:
There are four components in the foreground questions, as shown below:
Patient |
Intervention, Index diagnostic test or prognostic Indicator |
Comparison |
Outcome |
|---|---|---|---|
In children with Hand Foot Mouth Disease |
does treatment with antiviral (intervention) |
compared to no antiviral |
result in faster resolution of lesions? |
In patients with heart failure |
does the presence of ascites (prognostic Indicator) |
(compared to no ascites) – not stated, but implied in question |
increase the risk of mortality (in 1 year/3 years/5 years etc) |
The PICO framework encompasses the important elements of a focused, answerable question, which are the predominant questions we should be asking in our day-to-day patient encounters. The answers to these questions may not be readily available from the standard text. Even if they are, they may no longer be accurate when we find them. The best answers to these questions reside within the sea of up-to-date clinical literature, waiting for us to gather using a set of skills that our next article in the series will elaborate.
There are several advantages when we formulate questions using the PICO framework:2
Issues in patient care leading to questions1
These are broadly categorised into the issues relating to:
Prioritizing questions to be answered
Among the many questions that might surface during our practice, we may not have enough time or memory with the pressure of work to remember them all, let alone finding answers for them. The following is a rough guide on how to choose questions to answer (these are not in the order of importance):1
| Patient | ||
What are the important patient characteristics, like age, gender, disease, co-morbidities etc that we believe could affect how the intervention works? |
||
| Intervention, Index diagnostic test or prognostic Indicator | ||
What is the treatment/action/test/exposure or characteristic that we are trying to assess? |
||
| Comparison | ||
What are we comparing the “I” against? Another treatment/exposure, no treatment/placebo? |
||
| Outcome | ||
What is the main measure that we are interested in? We hope patient gets better in what sense?: More likelihood to survive (lower risk of mortality), less symptoms, shorter hospital stay, or better quality of life? Each patient, even with the same condition undergoing the same treatment, may have different wishes. |
||